Aurinia Pharmaceuticals - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
AUPH
Aurinia Pharmaceuticals is a biopharmaceutical company focused on delivering therapies for autoimmune diseases with high unmet medical needs. The company develops and markets therapies targeting conditions such as lupus nephritis, with a science-driven portfolio including LUPKYNIS and other autoimmune disease programs. It operates in the global biopharmaceutical landscape, collaborating on research, development, and patient access initiatives to improve outcomes for people living with autoimmune disorders.
No recent news for this company.
